All Releases
 |
PPD Enhances its Portfolio of EDC Services with Oracle® Remote Data Capture Onsite 4.5.3
Apr 22, 2008
|
9.7 KB |
|
| |
WILMINGTON, N.C. (April 22, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced that it has integrated Oracle's newest electronic data capture (EDC) solution into its suite of clinical trial management applications providing clients and investigators easier, faster navigation to collect and report real-time data for large-scale, global clini...
|
|
PPD Reports First Quarter 2008 Financial Results
Apr 22, 2008
|
57.4 KB |
|
| |
Highlights:
$690 million in new authorizations
Book-to-bill ratio of 1.51
Development segment net revenue growth of 15.9 percent over Q1 2007
Record cash flow from operations of $117 million
WILMINGTON, NC, April 22, 2008 - PPD, Inc. (Nasdaq: PPDI) today reported its financ...
|
|
PPD Earns CEO Cancer Gold StandardTM Accreditation
Apr 17, 2008
|
9.6 KB |
|
| |
WILMINGTON, N.C. (April 17, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced it has received the CEO Cancer Gold Standard™ accreditation from the CEO Roundtable on Cancer, recognizing the company's efforts to reduce cancer risks among employees and improve their overall health.
"According to the National Cance...
|
|
PPD to Present on Key Industry Topics at IIR CRO Partnerships
Apr 10, 2008
|
11.1 KB |
|
| |
WILMINGTON, N.C. (April 10, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced it will present on key industry topics at the 2008 IIR Partnerships with CROs conference held April 14-16 in Las Vegas. IIR has selected several PPD industry experts to speak on topics including financial strategies and CRO partnerships, single-sourcing...
|
|
New Jobs Follow New Tenant to North Carolina Research Campus
Apr 9, 2008
|
10.8 KB |
|
| |
(KANNAPOLIS, N.C.) - The North Carolina Research Campus announced today at a news conference that PPD, Inc. (PPD), a global contract research organization, is opening an office at the campus, which may bring 200 to 300 new jobs. The jobs will be added over a 24-to-36-month period and will focus on clinical research.
"When I promis...
|
|
Paul Covington to Retire from PPD
Apr 3, 2008
|
9.4 KB |
|
| |
WILMINGTON, N.C. (April 3, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced that Paul Covington, M.D., is retiring as executive vice president of development and chief medical officer effective June 30. He will serve as a special project adviser to PPD through January 2009 to assist with selected projects and the transition of his respons...
|
|
PPD Announces First Quarter 2008 Earnings Release, Webcast and Conference Call
Apr 2, 2008
|
8.6 KB |
|
| |
WILMINGTON, N.C., April 2, 2008 - PPD, Inc. (Nasdaq: PPDI) will release its first quarter 2008 financial results on Tuesday, April 22, 2008, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and Business Wire.
On Wedne...
|
|
PPD Names Mike Wilkinson Executive Vice President of Global Clinical Development
Mar 31, 2008
|
9.1 KB |
|
| |
WILMINGTON, N.C. (March 31, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Mike Wilkinson, Ph.D., as executive vice president of global clinical development. In this role, he will provide strategic leadership to the company's Phase II-IV operations in North America; Latin America; Europe, Middle East and Africa; and Asi...
|
|
PPD Confirms Takeda's NDA Filing of Alogliptin with U.S. Food and Drug Administration
Feb 28, 2008
|
9.0 KB |
|
| |
WILMINGTON, N.C. (February 28, 2008) - PPD, Inc. (Nasdaq: PPDI) today confirmed that Takeda Pharmaceutical Company Limited's new drug application (NDA) for alogliptin, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, has been accepted for filing by the U.S. Food and Drug Administration. PPD partnered with...
|
|
PPD Declares First Quarter Dividend
Feb 22, 2008
|
8.7 KB |
|
| |
WILMINGTON, N.C. (February 22, 2008) -- PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors declared a cash dividend for the first quarter of 2008 under its annual cash dividend policy. The quarterly cash dividend will equal $0.10 per share. The record date for the first quarter dividend is March 14, 2008, and the payment...
|
|
PPD Announces Plan to Repurchase Shares of its Common Stock
Feb 20, 2008
|
9.1 KB |
|
| |
WILMINGTON, N.C. (February 20, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced its plans to begin a stock repurchase program whereby up to $350 million of its common stock may be purchased from time to time in the open market.
The company made the decision to initiate a share repurchase program in view of the current...
|
|
PPD to Acquire InnoPharm Ltd.
Feb 6, 2008
|
8.7 KB |
|
| |
WILMINGTON, N.C. (February 6, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced it has signed an agreement to purchase InnoPharm Ltd., an independent contract research organization, or CRO, based in Smolensk, Russia. The acquisition will expand PPD's global reach with established offices in both Russia and Ukraine.
One of the firs...
|
|
PPD Reports Fourth Quarter and Year-End 2007 Financial Results
Feb 6, 2008
|
61.2 KB |
|
| |
Highlights:
Q4 2007 new authorizations of $613 million
Q4 2007 book to bill ratio of 1.44
Backlog at December 31, 2007 of $2.65 billion, an increase of 19 percent year-over-year
WILMINGTON, NC, February 6, 2008 - PPD, Inc. (Nasdaq: PPDI) today reported its...
|
|
PPD Expands Global Central Lab Services into China
Jan 23, 2008
|
8.0 KB |
|
| |
WILMINGTON, N.C. (January 23, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced that it has expanded its global central lab services into China through an exclusive agreement with Peking Union Lawke Biomedical Development Limited (PUL). The agreement allows PPD to begin immediately providing biopharmaceutical clients with its ful...
|
|
PPD Announces 4th Quarter and Year-End 2007 Earnings Release Webcast and Conference Call
Jan 10, 2008
|
6.2 KB |
|
| |
WILMINGTON, N.C., January 10, 2008 - PPD, Inc. (Nasdaq: PPDI) will release its fourth quarter and year-end 2007 financial results on Wednesday, February 6, 2008, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and PR Newswire....
|
|
CSS Informatics Signs Solutions Partner Agreement with Nimbus Partners
Jan 10, 2008
|
7.8 KB |
|
| |
WILMINGTON, N.C. (January 10, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced that CSS Informatics, the clinical and safety data management consulting services and proprietary e-technologies division of PPD, has entered into a solutions partner agreement with Nimbus Partners, a provider of process management software and servic...
|
|
PPD Updates 2007 Forecast; Issues Financial Guidance For 2008
Jan 8, 2008
|
24.2 KB |
|
| |
Highlights:
Net revenue projected to grow 20 percent in 2008
Discovery sciences forecast includes $40.0 million in anticipated milestones for the DPP-4 program with Takeda
EPS expected to grow 36 percent in 2008
WILMINGTON, NC, January 8, 2008 - PPD, Inc. (Nasdaq: PPDI) today u...
|
|
Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
Jan 4, 2008
|
6.2 KB |
|
| |
Osaka, Japan, January 4, 2008 --- Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc. submitted a new drug application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-IV (D...
|
|
PPD Names Senior Vice President for Europe, Middle East and Africa
Jan 2, 2008
|
6.6 KB |
|
| |
WILMINGTON, N.C. (January 2, 2008) - PPD, Inc. (Nasdaq: PPDI) today announced the appointment of Sebastian Pacios, M.D., as senior vice president of clinical operations for Europe, Middle East and Africa (EMEA). In this role, Dr. Pacios will oversee Phase II-IV clinical development for PPD's operations in these geographic regions.
...
|
|
Mathew to Lead PPD Drug Development Operations and Expansion in India
Dec 12, 2007
|
8.2 KB |
|
| |
WILMINGTON, N.C. (December 12, 2007) - PPD, Inc. (Nasdaq: PPDI) today announced the appointment of Philip Mathew, M.D., as director of strategic development, to lead the company's Phase II-IV operations and expansion in India.
Dr. Mathew will provide strategic leadership for PPD's drug development business on the Indian subcontine...
|
|
|
0.48
